AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentRevenue01Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentRevenue02Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentRevenue03Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentResults01Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentResults02Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentResults03Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentAssets01Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentAssets02Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentAssets03Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentLiabilities01Member AARTIIND2018-06-30in-bse-fin:OneReportableSegmentLiabilities01Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentLiabilities02Member AARTIIND2018-06-30in-bse-fin:OneReportableSegmentLiabilities02Member AARTIIND2018-04-012018-06-30in-bse-fin:OneReportableSegmentLiabilities03Member AARTIIND2018-06-30in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AARTIIND 2018-04-01 2019-03-31 2018-07-23 INR Lakhs First quarter Multi segment 2018-04-01 2018-06-30 Audited Standalone 10784800000.00 34000000.00 10818800000.00 6645600000.00 331600000.00 -381400000.00 512500000.00 461000000.00 377200000.00 1797500000.00 9744000000.00 1074800000.00 0.00 1074800000.00 230000000.00 -48000000.00 182000000.00 0.00 892800000.00 0.00 0.00 0.00 892800000.00 -147500000.00 745300000.00 0.00 0.00 892800000.00 0.00 406500000.00 5 10.98 10.98 0.00 0.00 10.98 10.98 1. The above results for the quarter ended 30th June, 2018 have been reviewed by the Audit Committee in their meeting held on 3rd August, 2018 and approved by the Board of Directors in their meeting held on 4th August, 2018.2. Company has entered into forward contracts to hedge its export contracts. Mark to market gain/(loss) for such contracts as at the end of reporting period are recognised in these statements. Mark to market gain/(loss) in respect of near term contracts amounting to (Rs 2,895) Lakhs is expensed off in the above P&L statement, while mark to market loss in respect of long term contracts amounting to (Rs 1,711) Lakhs are adjusted under Other Comprehensive Income. The component adjusted under Other Comprehensive Income will be appropriately treated in P&L when the underlying cash-flow impact accrues.3. Company had further recognised revaluation gain/(loss) to the extent of (Rs 723) lakhs in respect of its long term borrowings (ECBs) as at 30th June, 2018 and included the same in its Finance Costs appearing above.4. The Listed Non-Convertible Debenture of the Company aggregating to Rs 12,000 Lakhs as on 30th June, 2018 are secured by way of first pari passu charge on the Movable Fixed Assets of the Company at its premises located at Vapi, Jhagadia, Silvassa, Tarapur and Pithampur and the assets cover thereof exceeds 100% of the principal amount of the said debentures.5. Company retained its domestic credit ratings of AA- from CRISIL and India Ratings.6. Figures for the previous period have been regrouped or rearranged wherever necessary.7. The aforesaid Audited Financial Results will be uploaded on the Company's website www.aarti-industries.com and will also be available on the website of BSE Limited www.bseindia.com and the National Stock Exchange of India Limited www.nseindia.com for the benefit of the shareholders and investors. a) Speciality Chemicals 8484700000.00 b) Pharmaceuticals 1496700000.00 c) Home & Personal Care Chemicals 803400000.00 0.00 10784800000.00 a) Speciality Chemicals 1483300000.00 b) Pharmaceuticals 260000000.00 c) Home & Personal Care Chemicals 19900000.00 461000000.00 227400000.00 1. Figures for the previous period have been regrouped or rearranged wherever necessary. 1074800000.00 a) Speciality Chemicals 29279400000.00 b) Pharmaceuticals 8179300000.00 c) Home & Personal Care Chemicals 2425500000.00 3070000000.00 a) Speciality Chemicals 3928500000.00 b) Pharmaceuticals 665600000.00 c) Home & Personal Care Chemicals 426700000.00 1643600000.00